{
    "clinical_study": {
        "@rank": "38547", 
        "acronym": "N3D", 
        "arm_group": [
            {
                "arm_group_label": "NOVOCART 3D", 
                "arm_group_type": "Experimental", 
                "description": "Scaffold assisted autologous chondrocyte Implant"
            }, 
            {
                "arm_group_label": "Microfracture", 
                "arm_group_type": "Active Comparator", 
                "description": "considered a typical treatment for articular cartilage repair"
            }
        ], 
        "brief_summary": {
            "textblock": "This study is to  NOVOCART 3D relative to Microfracture for the treatment of knee cartilage\n      defects. Efficacy will be evaluated by both pain and function. Safety will also be\n      evaluated."
        }, 
        "brief_title": "NOVOCART\u00ae3D for Treatment of Articular Cartilage of the Knee", 
        "completion_date": {
            "#text": "August 2021", 
            "@type": "Anticipated"
        }, 
        "condition": "Articular Cartilage of the Femoral Condyle Between 4-6cm2", 
        "detailed_description": {
            "textblock": "Subjects with articular knee defects will be randomized to receive either Microfracture or\n      NOVOCART 3D.  Subjects will be followed for five years in total and will be evaluated for\n      safety and efficacy."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Greater than 18 years old\n\n          -  Isolated articular cartilage lesions on the femoral condyle 2-6 cm2\n\n          -  Minimum score on the KOOS questionnaire\n\n        Exclusion Criteria:\n\n          -  Instability of the knee joint\n\n          -  Arthritis\n\n          -  Autoimmune disease\n\n          -  Immune suppression\n\n          -  Prior surgical treatment using mosaicplasty, autologous chondrocyte implantation\n             and/or microfracture (debridement and lavage are acceptable beyond three months from\n             baseline)\n\n          -  Bone disease\n\n          -  Any degenerative muscular, connective tissue or neurological condition or other\n             disease process that would interfere with healing or the evaluation of outcome\n             measures."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "55 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "233", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 17, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01957722", 
            "org_study_id": "AAG-G-H-1220"
        }, 
        "intervention": [
            {
                "arm_group_label": "Microfracture", 
                "description": "Surgical procedure which creates a marrow clot in the prepare cartilage defect.", 
                "intervention_name": "microfracture", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "NOVOCART 3D", 
                "intervention_name": "NOVOCART 3D", 
                "intervention_type": "Biological"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "lastchanged_date": "April 4, 2014", 
        "location": [
            {
                "contact": {
                    "email": "laura.goldsmith@kerlanjobe.com", 
                    "last_name": "Laura Goldsmith", 
                    "phone": "310-665-7200", 
                    "phone_ext": "6255"
                }, 
                "facility": {
                    "address": {
                        "city": "Los Angeles", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90045"
                    }, 
                    "name": "Kerlan Jobe Orthopedic Foundation"
                }, 
                "investigator": {
                    "last_name": "Ralph Gambardella", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "ggratto@sghs.org", 
                    "last_name": "Gwen Gratto-Cox", 
                    "phone": "912-262-9961", 
                    "phone_ext": "122"
                }, 
                "facility": {
                    "address": {
                        "city": "Brunswick", 
                        "country": "United States", 
                        "state": "Georgia", 
                        "zip": "31525"
                    }, 
                    "name": "Glynn Brunswick Memorial Authority/ SE Georgia Health System"
                }, 
                "investigator": {
                    "last_name": "Melvin Deese", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "lthorp@advancedortho.me", 
                    "last_name": "Lisa Thorpe", 
                    "phone": "804-527-6803"
                }, 
                "facility": {
                    "address": {
                        "city": "Richmond", 
                        "country": "United States", 
                        "state": "Virginia", 
                        "zip": "23294"
                    }, 
                    "name": "Advanced Orthopedics"
                }, 
                "investigator": {
                    "last_name": "Kenneth Zaslav", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Phase 3, Prospective, Randomized, Partially Blinded Multi-Center Study to Measure the Safety and Efficacy of NOVOCART 3D Compared ot Microfracture in Teh Treatment of Articular Cartilage Defects", 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "July 2018", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "As measured by change in score from Baseline in KOOS score", 
                "measure": "Pain", 
                "safety_issue": "Yes", 
                "time_frame": "24 months post treatment"
            }, 
            {
                "description": "As measured by change in score from Baseline in KOOS score", 
                "measure": "Function", 
                "safety_issue": "No", 
                "time_frame": "24 months post treatment"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01957722"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Aesculap Biologics, LLC", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Aesculap Biologics, LLC", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "January 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}